Global Cancer/Tumor Profiling Market Size by Type (Epigenetic, Metabolomic), By Technology (Mass Spectrometry, Microarray), By Application (Patient Monitoring, Research) By Geographic Scope and Forecast

Cancer/Tumor Profiling Market Size And Forecast

Cancer/Tumor Profiling Market size was valued at USD 10.1 Billion in 2023 and is projected to reach USD 22.26 Billion by 2031 growing at a CAGR of 9.75% from 2024 to 2031.Tumor profiling is a molecular examination of tumor samples that detects genetic mutations, expression patterns and other indicators. This information aids in understanding the tumor's behavior, directing therapy decisions and forecasting patient outcome. It helps to personalize medicines, increasing efficacy while minimizing side effects.Tumor profiling is now utilized to personalize cancer treatments such as targeted medicines and immunotherapies. It enables doctors to choose the most effective treatment strategies based on specific tumor features. Furthermore, it aids in the discovery of clinical trial prospects for patients, promoting progress in cancer research.Tumor profiling is predicted to become more widely used in clinical practice in the future. Technological and data analytics innovations will improve profiling precision, resulting in more accurate prognostic and predictive models. As our understanding of cancer biology evolves, tumor profiling may also enable early detection and preventive strategies, significantly improving patient outcomes.

Global Cancer/Tumor Profiling Market Dynamics

The key market dynamics that are shaping the global Cancer/Tumor Profiling Market include:

Key Market Drivers:

Increasing Global Cancer Incidence: The Cancer/Tumor Profiling Market is being driven by the rising global cancer incidence. According to the World Health Organization's GLOBOCAN 2020 report, there were approximately 19.3 million new cancer cases worldwide in 2020.

Advances in Personalized Medicine: The transition to individualized therapy benefits the tumor profiling business. According to the National Institutes of Health (NIH), over 75% of cancer therapy research currently focuses on specific molecular profiles, underscoring the importance of tumor profiling.

Increasing Adoption of Next-Generation Sequencing (NGS): The growing use of NGS in cancer diagnostics improves tumor profiling. According to the American Association for Cancer Research (AACR), more than 60% of cancer centers in the United States will use NGS-based tumor profiling by 2022, indicating its increasing adoption.

Key Challenges:

Complex Data Interpretation: It might be difficult to interpret the large amounts of data generated by tumor profiling. The American Association for Cancer Research (AACR) emphasizes that combining genomic, transcriptomic and proteomic data necessitates advanced tools and knowledge, further complicating the process.

Limited Standardization:A lack of standardization in tumor profiling methods can stifle market expansion. The World Health Organization (WHO) observes that heterogeneity in protocols and interpretations between laboratories impacts the consistency and dependability of results.

Regulatory Hurdles: The regulatory approval process for tumor profiling tests can be time-consuming and complex. According to the US Food and Drug Administration (FDA), traversing regulatory routes for new diagnostic tests requires extensive validation and compliance measures.

Key Trends:

Integration With Artificial Intelligence:Tumor profiling is rapidly integrating with AI to improve data processing and interpretation. According to a National Cancer Institute (NCI) publication, AI algorithms are being employed to increase prediction accuracy for treatment responses and patient outcomes.Expanding The Liquid Biopsy: The use of liquid biopsies in tumor profiling is increasing. A study published in the Journal of Clinical Oncology found that liquid biopsy procedures, which examine tumor DNA in blood samples, are a less intrusive alternative to standard biopsies.Advancement Of Multi-Omics Approaches: There is a shift toward multi-omics techniques that incorporate genomes, proteomics and metabolomics. According to the American Association for Cancer Research (AACR), combining several forms of biological data gives a more complete picture of tumor features.

Global Cancer/Tumor Profiling Market Regional Analysis

Here is a more detailed regional analysis of the global Cancer/Tumor Profiling Market:

North America:

According to Verified Market Research, North America is expected to dominate the global Cancer/Tumor Profiling Market.

North America, particularly the United States, has a considerable cancer burden, which drives the demand for tumor profiling. According to the American Cancer Society's Cancer Statistics 2024 study, roughly 1.9 million new cancer cases were recognized in the United States in 2023, with an estimated 609,820 fatalities.

The rising incidence and fatality rates highlight the need for better tumor profiling methods. These technologies provide early detection, accurate diagnosis and individualized treatment options, allowing healthcare providers to adjust medicines to individual tumor features. By using tumor profiling, the healthcare system can improve patient outcomes and the overall effectiveness of cancer treatment, addressing the critical problems provided by the rising cancer burden.

Asia Pacific:

According to Verified Market Research, Asia Pacific is fastest growing region in global Cancer/Tumor Profiling Market.

The Asia-Pacific Cancer/Tumor Profiling Market is continuously expanding, propelled by grew cancer incidence, significant healthcare investments and technical improvements. The International Agency for Research on Cancer (IARC) estimated that Asia would account for more than 57% of all cancer cases in 2020, indicating a considerable geographical burden. As a result, countries in the region are increasing healthcare spending to improve diagnostic and treatment capacity.

Advances such as next-generation sequencing are transforming tumor profiling, allowing for more precise and economical assessments of genetic alterations and biomarkers. The combination of high cancer rates, greater funding and technology advancements is driving market expansion, encouraging the development of personalized treatment options and improving patient outcomes throughout Asia-Pacific.

Global Cancer/Tumor Profiling Market: Segmentation Analysis

The Global Cancer/Tumor Profiling Market is segmented on the basis of Type, Technology, Application, and Geography.

Cancer/Tumor Profiling Market, By Type

• Genomic
• Proteomic
• Epigenetic
• Metabolomic

Based on Type, Global Cancer/Tumor Profiling Market is divided into Genomic, Proteomic, Epigenetic, Metabolomic. Genomic profiling is currently the most popular method of tumor profiling in the world due to its comprehensive capacity to assess genetic alterations and variants. It delivers vital insights for individualized treatment, resulting in widespread adoption and commercial leadership.

Cancer/Tumor Profiling Market, By Technology

• Next Generation Sequencing
• Polymerase Chain Reaction
• Immunohistochemistry
• In-Situ Hybridization
• Mass Spectrometry
• Microarray

Based on Technology, the Global Cancer/Tumor Profiling Market is separated into Next Generation Sequencing, Polymerase Chain Reaction, Immunohistochemistry, In-Situ Hybridization, Mass Spectrometry, Microarray. The global Cancer/Tumor Profiling Market is dominated by Next Generation Sequencing (NGS) because to its complete and deep genomic analysis capabilities. Its capacity to effectively identify various mutations and biomarkers makes it a top choice for advanced cancer diagnostics and personalized treatment.

Global Cancer/Tumor Profiling Market, By Application

• Diagnosis
• Prognosis
• Treatment Selection
• Patient Monitoring
• Research

Based on Application, Global Cancer/Tumor Profiling Market is divided into Diagnosis, Prognosis, Treatment Selection, Patient Monitoring, Research. In the worldwide Cancer/Tumor Profiling Market, diagnosis is the most common application. It is related to the crucial necessity for precise cancer diagnosis and characterization. Advanced diagnostic techniques allow for early detection and individualized treatment planning, resulting in significant market growth in this category.

Key Players

The "Global Cancer/Tumor Profiling Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Lucence Health, Inc., F. Hoffmann-La Roche Ltd, Caris Life Sciences, ACT Genomics Co., LTD, Thermo Fisher Scientific, Inc., Strand Life Sciences, IMB Dx, Inc., Illumina, Inc., Guardant Health, QIAGEN, Ribomed Biotechnologies Inc., HTG Molecular Diagnostics, Inc., NanoString, NeoGenomics Laboratories and Exact Sciences Corporation.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

• In May 2023, Lucene Health Inc. developed LucenceINSIGHT, a new multi-cancer early detection (MCED) blood test. The first MCED test, which is a ctDNA-based liquid biopsy test capable of screening for ten prevalent malignancies in a single blood draw, is being launched globally.In May 2022, QIAGEN introduced the Thera screen EGFR Plus RGQ PCR Kit which is a new in-vitro diagnostic test for sensitive EGFR mutation analysis. This allows physicians to more effectively guide treatment for non-small cell lung cancer (NSCLC).
• To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team at Verified Market Research.
• Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter's five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
• Customization of the Report
• In case of any Queries or Customization Reqirements please connect with our sales team, who will ensure that your requirements are met.